- Sales increased +17.5% in local currency – generics grew even faster at +24.9%
- Margins at constant exchange rates rose to 18.2% (EBIT) and 28.9% (EBITDA)
- Reported results in CHF affected by negative currency translation effect
- Market leadership nevertheless strengthened – Quality Matters!
- Short- and medium-term targets confirmed